Jaume Català Mora, MD, PhD
Pediatric Ophthalmologist at Sant Joan de Déu Children's Hospital in Barcelona, Spain

Research Approach

Pediatric ophthalmology, gene therapy, gene editing, Vitreo-retinal diseases


Developed and implemented a new screening program for early detection of childhood blindness at Sant Joan de Déu Children's Hospital
Led the development of a new gene therapy treatment for retinoblastoma, which is now in clinical trials
Received numerous awards for his work, including the Spanish Association of Pediatric Ophthalmology Award for Best Clinical Research and the American Academy of Ophthalmology's Honored Award


Dr. Català Mora was born in Lloseta, Mallorca. He received his medical degree from the University of Navarra and his residency training in ophthalmology at Bellvitge Hospital in Barcelona. He founded the pediatric ophthalmology retinal department at the Sant Joan de Déu Children’s Hospital in Barcelona. He completed his education in pediatric retinal diseases at the Curie Institute, Oregon Health & Science University Casey Eye Institute and at Memorial Sloan Kettering Cancer Center.
Dr. Català Mora is a leading expert in pediatric ophthalmology. His research focuses on the development of new treatments for pediatric eye diseases, including gene therapy and gene editing. He has published over 50 papers in peer-reviewed journals and has given numerous presentations at international conferences.
Dr. Català Mora is a passionate advocate for children with eye diseases. He is committed to finding new treatments that will improve the lives of these children and preserve their vision.